Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain
NCT ID: NCT04355871
Last Updated: 2023-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4035 participants
OBSERVATIONAL
2020-03-18
2020-04-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of COVID-19 Prognostic Factors in Hospitalized Patients
NCT05102708
Risk Factors and Prognoses in Patients Hospitalized for COVID-19
NCT04824677
COVID19 Hospitilized in Clinica Pasteur of Neuquen (Argentina)
NCT05087394
Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry
NCT04347278
International COVID19 Clinical Evaluation Registry,
NCT04334291
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Ethics Committee for Research with Medicines of Hospital General Universitario Gregorio Marañón approved the study and waived informed consent for the collection of clinical data.
Investigators from participating centers were asked to include the first consecutive hospitalized patients (up to 100) meeting the study criteria from the start of the epidemic until March 17, 2020.
The data source was the electronic medical records. All data were entered directly by personnel at each institution using an online case report form (CRF), that satisfied local requirements of data confidentiality.
The variables registered included administrative data, epidemiological information, type of clinical specimen in which the diagnosis was confirmed, and the RT-PCR cycle threshold (Ct) of the confirmatory gene. We also registered demographics, comorbidities and current medications, signs and symptoms at admission, baseline laboratory tests results, chest X-ray findings at baseline and during follow-up, complications during hospitalization, medications with potential activity against COVID-19, and supportive treatments including oxygen therapy, admission to intensive care unit (ICU), mechanical ventilation (intubation), and use of adjuvant anti-inflammatory medications such as tocilizumab and systemic corticosteroids. Drug-related adverse events of medications for COVID-19 needing discontinuation were also recorded. The clinical status of the patients as of April 17, 2020, was categorized as discharged alive (with the date of discharge), alive and currently hospitalized, and death (with the date of death).
The primary endpoint is all-cause mortality at day 28, and the secondary endpoint is the need for mechanical ventilation. Baseline was the date of hospital admission. The follow-up censoring date is April 17, 2020.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospital admission
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundacion SEIMC-GESIDA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jose Ramón Arribas, MD
Role: PRINCIPAL_INVESTIGATOR
H. Univ. La Paz
Juan Berenguer, MD
Role: PRINCIPAL_INVESTIGATOR
H. Univ. Gregorio Marañón
Pablo Ryan, MD
Role: PRINCIPAL_INVESTIGATOR
H. Univ. Infanta Leonor
Jesús Rodriguez Baños, MD
Role: PRINCIPAL_INVESTIGATOR
H. Univ. Virgen Macarena
Jordi Carratala, MD
Role: PRINCIPAL_INVESTIGATOR
H. Univ. de Bellvitge
Jerónimo Pachón, MD
Role: PRINCIPAL_INVESTIGATOR
H. Univ. VIrgen del Rocio
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Comp. Hosp. Univ. A Coruña
A Coruña, , Spain
H. Quiron A Coruña
A Coruña, , Spain
H. de Alcaniz
Alcañiz, , Spain
H. Gral Univ. de Alicante
Alicante, , Spain
H. Univ. San Juan de Alicante
Alicante, , Spain
H. Univ. de la Ribera
Alzira, , Spain
H. Santos Reyes
Aranda de Duero, , Spain
Hospital Alto Deba
Arrasate / Mondragón, , Spain
H. Dr. Jose Molina Orosa
Arrecife, , Spain
Complejo Asistencial de Avila
Ávila, , Spain
Consorcio Sanitari Integral (CAIDM)
Barcelona, , Spain
H. Clinic
Barcelona, , Spain
H. del Mar
Barcelona, , Spain
H. Parc Sanitari Sant Joan de Deu
Barcelona, , Spain
H. Santa Creu y Sant Pau
Barcelona, , Spain
H. Univ. de Bellvitge
Barcelona, , Spain
H. Vall d'Hebron
Barcelona, , Spain
Hospital CIMA-Sanitas
Barcelona, , Spain
SCIAS H. de Barcelona
Barcelona, , Spain
H. Clinica de Benidorm
Benidorm, , Spain
H. de Cruces
Bilbao, , Spain
H. San Eloy_Barakaldo
Bilbao, , Spain
H. Univ. de Basurto
Bilbao, , Spain
H. Urduliz-Alfredo Espinosa
Bilbao, , Spain
H. Gral de La Palma
Breña Alta, , Spain
H. de Puerto Real
Cadiz, , Spain
H. de Calahorra
Calahorra, , Spain
H. Sant Jaume de Calella
Calella, , Spain
H. Univ Santa Lucia
Cartagena, , Spain
H. Univ de Henares
Coslada, , Spain
Hospital Marina Salud de Dénia
Denia, , Spain
Hospital Don Benito-Villanueva de la Serena
Don Benito, , Spain
H. Gral Univ. de Elche
Elche, , Spain
H. Univ. del Vinalopo
Elche, , Spain
Comp. Hospt. Univ. de Ferrol
Ferrol, , Spain
H. Francesc de Borja
Gandia, , Spain
H. Comarcal de Blanes
Girona, , Spain
H. de Figueres
Girona, , Spain
H. Josep Trueta
Girona, , Spain
H. Clinico San Cecilio
Granada, , Spain
Hospital HLA Inmaculada
Granada, , Spain
H. de Guadalajara
Guadalajara, , Spain
H. de Guadarrama
Guadarrama, , Spain
H. Juan Ramón Jiménez
Huelva, , Spain
H. Riotinto
Huelva, , Spain
H. Can Misses
Ibiza Town, , Spain
H. Universitario de Jaén
Jaén, , Spain
H. Univ. de Jerez de la Frontera
Jerez de la Frontera, , Spain
H. Univ Insular de Gran Canaria
Las Palmas de Gran Canaria, , Spain
H. Universitario de Gran Canaria Dr. Negrin
Las Palmas de Gran Canaria, , Spain
H. Univ. Severo Ochoa
Leganés, , Spain
H. San Pedro
Logroño, , Spain
H. Univ. Menez Rafael Mendez
Lorca, , Spain
H. Lucus Augusti
Lugo, , Spain
H. 12 de Octubre
Madrid, , Spain
H. Clinica Univ. de Navarra_ Campus Madrid
Madrid, , Spain
H. Clinico San Carlos
Madrid, , Spain
H. Fundacion Jiménez Díaz
Madrid, , Spain
H. Gral de la Defensa Gomez Ulla
Madrid, , Spain
H. HLA Univ. Moncloa
Madrid, , Spain
H. HM Sanchinarro
Madrid, , Spain
H. Puerta de Hierro
Madrid, , Spain
H. Univ HM Madrid
Madrid, , Spain
H. Univ Principe de Asturias
Madrid, , Spain
H. Univ. de Alcorcón
Madrid, , Spain
H. Univ. de Getafe
Madrid, , Spain
H. Univ. de Móstoles
Madrid, , Spain
H. Univ. Gregorio Marañon
Madrid, , Spain
H. Univ. HM Monteprincipe
Madrid, , Spain
H. UNiv. HM Puerta del Sur
Madrid, , Spain
H. Univ. Infanta Leonor
Madrid, , Spain
H. Univ. La Paz
Madrid, , Spain
H. Univ. La Princesa
Madrid, , Spain
H. Univ. Ramón y Cajal
Madrid, , Spain
H. Univ. Rey Juan Carlos
Madrid, , Spain
H. Costa del Sol
Marbella, , Spain
H. de Mataro
Mataró, , Spain
H. Marbella Internacional
Málaga, , Spain
H. Virgen de la Victoria
Málaga, , Spain
H. de Melilla
Melilla, , Spain
H. de Mendaro
Mendaro, , Spain
H. Virgen de la Arrixaca
Murcia, , Spain
H. Vega Baja
Orihuela, , Spain
H. Univ. Central de Asturias
Oviedo, , Spain
H. de Palamos
Palamós, , Spain
H. Son Espases
Palma de Mallorca, , Spain
H. Son Llatzer
Palma de Mallorca, , Spain
H. Clinica Univ. Navarra
Pamplona, , Spain
H. Virgen del Puerto
Plasencia, , Spain
H. El Bierzo
Ponferrada, , Spain
H. Do Salnes
Pontevedra, , Spain
H. UNiv. Los Arcos del Mar Menor
Pozo-Aledo, , Spain
H. Santa Barbara
Puertollano, , Spain
H. Parc Tauli
Sabadell, , Spain
Complejo Asist. Univ. de Salamanca
Salamanca, , Spain
H. de Donostia
San Sebastián, , Spain
H. Infanta Sofia
San Sebastián de los Reyes, , Spain
H. de l'Esperit Sant
Santa Coloma de Gramenet, , Spain
H. U. de Canarias
Santa Cruz de Tenerife, , Spain
H. Univ. Nuestra Sra. de la Candelaria
Santa Cruz de Tenerife, , Spain
H. Univ. Marques de Valdecilla
Santander, , Spain
H. Clinico Univ. Santiago de Compostela
Santiago de Compostela, , Spain
H. Univ de Valme
Seville, , Spain
H. Univ. Virgen del Rocio
Seville, , Spain
H. Univ. Virgen Macarena
Seville, , Spain
H. Virgen Macarena
Seville, , Spain
H. Univ Joan XXIII
Tarragona, , Spain
H. Mutua de Terrasa
Terrassa, , Spain
Complejo Hospitalario Virgen de la Salud
Toledo, , Spain
H. Univ. HM Torrelodones
Torrelodones, , Spain
H. Quiron Salud Torrevieja
Torrevieja, , Spain
H. Virgen de la Cinta
Tortosa, , Spain
H. Reina Sofia de Tudela
Tudela, , Spain
H. Arnau de Vilanova-Lliria
Valencia, , Spain
H. Clinico Univ. de Valencia
Valencia, , Spain
H. de Sagunto
Valencia, , Spain
H. Univ. y Polit. La Fe
Valencia, , Spain
H. Clin. Univ. de Valladolid
Valladolid, , Spain
H. Rio Hortega
Valladolid, , Spain
H. Alvaro Cunqueiro
Vigo, , Spain
H. de Viladecans
Viladecans, , Spain
H. de la Marina Baixa
Villajoyosa, , Spain
Hospital de la Plana
Villarreal de Huerva, , Spain
H. Univ de Alava
Vitoria-Gasteiz, , Spain
H. Virgen de la Concha
Zamora, , Spain
H. Lozano Blesa
Zaragoza, , Spain
H. Miguel Servet
Zaragoza, , Spain
H. Ntra. Sra. de Gracia
Zaragoza, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVID-19/SEIMC-FSG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.